Anavex Life Sciences (AVXL) Net Income (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Anavex Life Sciences | 266.20 Mn | 134.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 47.61% |
| Sep 30, 2025 | 25.00% |
| Jun 30, 2025 | -15.55% |
| Mar 31, 2025 | 7.94% |
| Dec 31, 2024 | -15.74% |
| Sep 30, 2024 | 3.85% |
| Jun 30, 2024 | -15.82% |
| Mar 31, 2024 | -22.32% |
| Dec 31, 2023 | 15.02% |
| Sep 30, 2023 | 10.05% |
| Jun 30, 2023 | 13.94% |
| Mar 31, 2023 | -1.04% |
| Dec 31, 2022 | 9.23% |
| Sep 30, 2022 | -15.55% |
| Jun 30, 2022 | -18.49% |
| Mar 31, 2022 | 4.09% |
| Dec 31, 2021 | 7.14% |
| Sep 30, 2021 | -15.11% |
| Jun 30, 2021 | -24.83% |
| Mar 31, 2021 | -3.82% |
| Dec 31, 2020 | -31.68% |
| Sep 30, 2020 | 8.04% |
| Jun 30, 2020 | 10.36% |
| Mar 31, 2020 | -9.78% |
| Dec 31, 2019 | -17.58% |
| Sep 30, 2019 | 14.04% |
| Jun 30, 2019 | 10.00% |
| Mar 31, 2019 | -4.73% |
| Dec 31, 2018 | -23.73% |
| Sep 30, 2018 | -96.28% |
| Jun 30, 2018 | 40.04% |
| Mar 31, 2018 | -17.07% |
| Dec 31, 2017 | 21.25% |
| Sep 30, 2017 | -42.78% |
| Jun 30, 2017 | -133.05% |
| Mar 31, 2017 | 50.77% |
| Dec 31, 2016 | 51.67% |
| Sep 30, 2016 | -190.62% |